Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Spencer, T. Articles by Seidman, L. Search for Related Content PubMed Citation Articles by Spencer, T. Articles by Seidman, L.

Effectiveness and Tolerability of Tomoxetine in Adults With Attention Deficit Hyperactivity Disorder

OBJECTIVE: The authors assessed the experimental noradrenergic compound tomoxetine as an alternative treatment for adult attention deficit hyperactivity disorder (ADHD). METHOD: They conducted a double-blind, placebo-controlled, crossover study of tomoxetine in 22 adults with well-characterized ADHD. RESULTS: Treatment with tomoxetine at an average oral dose of 76 mg/day was well tolerated. Drug-specific improvement in ADHD symptoms was highly significant overall and sufficiently robust to be detectable in a parallel-groups comparison restricted to the first 3 weeks of the protocol. Eleven of 21 patients showed improvement after receiving tomoxetine, compared with only two of 21 patients who improved after receiving placebo. Significant tomoxetine-associated improvement was noted on neuropsychological measures of inhibitory capacity from Stroop tests. CONCLUSIONS: This preliminary study showed that tomoxetine was effective in treating adult ADHD and was well tolerated. These promising results provide support for further studies of tomoxetine over an extended period of treatment.

This article has been cited by other articles:

				L. A. Adler, S. V. Faraone, T. J. Spencer, D. Michelson, F. W. Reimherr, S. J. Glatt, B. K. Marchant, and J. Biederman The Reliability and Validity of Self- and Investigator Ratings of ADHD in Adults J Atten Disord, May 1, 2008; 11(6): 711 - 719. [Abstract] [PDF]

				M. A. Davidson Literature Review: ADHD in Adults: A Review of the Literature J Atten Disord, May 1, 2008; 11(6): 628 - 641. [Abstract] [PDF]

				A.-C. Bedard and R. Tannock Anxiety, Methylphenidate Response, and Working Memory in Children With ADHD J Atten Disord, March 1, 2008; 11(5): 546 - 557. [Abstract] [PDF]

				L. G. Almeida Montes, A. O. Hernandez Garcia, and J. Ricardo-Garcell ADHD Prevalence in Adult Outpatients With Nonpsychotic Psychiatric Illnesses J Atten Disord, September 1, 2007; 11(2): 150 - 156. [Abstract] [PDF]

				G. Chouinard The Search for New Off-Label Indications for Antidepressant, Antianxiety, Antipsychotic and Anticonvulsant Drugs Focus, September 1, 2006; 4(4): 528. [Full Text] [PDF]

				S Prasad A new paradigm for developing drugs in children: atomoxetine as a model Arch. Dis. Child., February 1, 2005; 90(suppl_1): i13 - i16. [Abstract] [Full Text] [PDF]

				J Barton Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder Arch. Dis. Child., February 1, 2005; 90(suppl_1): i26 - i29. [Abstract] [Full Text] [PDF]

				J. J. McGough and R. A. Barkley Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder Am J Psychiatry, November 1, 2004; 161(11): 1948 - 1956. [Abstract] [Full Text] [PDF]

				D. K. Kelsey, C. R. Sumner, C. D. Casat, D. L. Coury, H. Quintana, K. E. Saylor, V. K. Sutton, J. Gonzales, S. K. Malcolm, K. J. Schuh, et al. Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial Pediatrics, July 1, 2004; 114(1): e1 - e8. [Abstract] [Full Text] [PDF]

				S. V. Faraone, T. J. Spencer, C. B. Montano, and J. Biederman Attention-Deficit/Hyperactivity Disorder in Adults: A Survey of Current Practice in Psychiatry and Primary Care Arch Intern Med, June 14, 2004; 164(11): 1221 - 1226. [Abstract] [Full Text] [PDF]

				B Toone Attention deficit hyperactivity disorder in adulthood J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 523 - 525. [Full Text] [PDF]

				L. S Eiland and A. L Guest Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder Ann. Pharmacother., January 1, 2004; 38(1): 86 - 90. [Abstract] [Full Text] [PDF]

				I. D. Maidment The Use of Antidepressants to Treat Attention Deficit Hyperactivity Disorder in Adults J Psychopharmacol, September 1, 2003; 17(3): 332 - 336. [Abstract] [PDF]

				M. Weiss and C. Murray Assessment and management of attention-deficit hyperactivity disorder in adults Can. Med. Assoc. J., March 18, 2003; 168(6): 715 - 722. [Abstract] [Full Text] [PDF]

				D. Coghill Current issues in child and adolescent psychopharmacology. Part 1: Attention-deficit hyperactivity and affective disorders Advan. Psychiatr. Treat., March 1, 2003; 9(2): 86 - 94. [Abstract] [Full Text] [PDF]

				J. Biederman, J. H. Heiligenstein, D. E. Faries, N. Galil, R. Dittmann, G. J. Emslie, C. J. Kratochvil, H. F. Laws, and K. J. Schuh Efficacy of Atomoxetine Versus Placebo in School-Age Girls With Attention-Deficit/Hyperactivity Disorder Pediatrics, December 1, 2002; 110(6): e75 - 75. [Abstract] [Full Text] [PDF]

				D. Michelson, A. J. Allen, J. Busner, C. Casat, D. Dunn, C. Kratochvil, J. Newcorn, F. R. Sallee, R. B. Sangal, K. Saylor, et al. Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study Am J Psychiatry, November 1, 2002; 159(11): 1896 - 1901. [Abstract] [Full Text] [PDF]

				J. S. Franowicz, L. E. Kessler, C. M. D. Borja, B. K. Kobilka, L. E. Limbird, and A. F. T. Arnsten Mutation of the alpha 2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine J. Neurosci., October 1, 2002; 22(19): 8771 - 8777. [Abstract] [Full Text] [PDF]

				M. F. Dorrego, L. Canevaro, G. Kuzis, L. Sabe, and S. E. Starkstein A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder: Preliminary Findings J Neuropsychiatry Clin Neurosci, August 1, 2002; 14(3): 289 - 295. [Abstract] [Full Text] [PDF]

				D. Michelson, D. Faries, J. Wernicke, D. Kelsey, K. Kendrick, F. R. Sallee, T. Spencer, and the Atomoxetine ADHD Study Group Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study Pediatrics, November 1, 2001; 108(5): e83 - 83. [Abstract] [Full Text] [PDF]

				T. Spencer, J. Biederman, T. Wilens, S. Faraone, J. Prince, K. Gerard, R. Doyle, A. Parekh, J. Kagan, and S. K. Bearman Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder Arch Gen Psychiatry, August 1, 2001; 58(8): 775 - 782. [Abstract] [Full Text] [PDF]

				M. A. SULLIVAN and F. RUDNIK-LEVIN Attention Deficit/Hyperactivity Disorder and Substance Abuse: Diagnostic and Therapeutic Considerations Ann. N.Y. Acad. Sci., June 1, 2001; 931(1): 251 - 270. [Abstract] [Full Text] [PDF]

				T. J. Spencer, J. Biederman, S. Faraone, E. Mick, B. Coffey, D. Geller, J. Kagan, S. K. Bearman, and T. Wilens Impact of Tic Disorders on ADHD Outcome Across the Life Cycle: Findings From a Large Group of Adults With and Without ADHD Am J Psychiatry, April 1, 2001; 158(4): 611 - 617. [Abstract] [Full Text]

				T. E. Wilens, T. J. Spencer, J. Biederman, K. Girard, R. Doyle, J. Prince, D. Polisner, R. Solhkhah, S. Comeau, M. C. Monuteaux, et al. A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults Am J Psychiatry, February 1, 2001; 158(2): 282 - 288. [Abstract] [Full Text]

				D. E. Faries, I. Yalcin, D. Harder, and J. H. Heiligenstein Validation of the ADHD Rating Scale as a clirlician administered and scored instrument J Atten Disord, January 1, 2001; 5(2): 107 - 115. [Abstract] [PDF]

				T. E. Wilens, T. J. Spencer, and J. Biederman A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder J Atten Disord, January 1, 2001; 5(4): 189 - 202. [Abstract] [PDF]

				T. E. Wilens, J. Biederman, T. J. Spencer, J. Bostic, J. Prince, M. C. Monuteaux, J. Soriano, C. Fine, A. Abrams, M. Rater, et al. A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder Am J Psychiatry, December 1, 1999; 156(12): 1931 - 1937. [Abstract] [Full Text]

				F. R. Levin, S. M. Evans, and H. D. Kleber Alcohol & Drug Abuse: Practical Guidelines for the Treatment of Substance Abusers With Adult Attention-Deficit Hyperactivity Disorder Psychiatr Serv, August 1, 1999; 50(8): 1001 - 1003. [Full Text] [PDF]

				J. Biederman A 55-Year-Old Man With Attention-Deficit/Hyperactivity Disorder JAMA, September 23, 1998; 280(12): 1086 - 1092. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us